Stage III Oral Cavity Squamous Cell Carcinoma
5 clinical trials · Condition
◉ Watch Stage III Oral Cavity Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery (NCT03342911) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-11-13 |
| Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer (NCT02827838) | Wake Forest University Health Sciences | 2017-01-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932) | Case Comprehensive Cancer Center | 2015-03-03 |
| TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma (NCT01542931) | Shanghai Jiao Tong University School of Medicine | 2008-01-01 |
Track Stage III Oral Cavity Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.